Genitourinary Cancer Treatment Center

The Lank Center for Genitourinary Oncology includes world-renowned physician-scientists and dedicated clinicians with expertise in diagnosing and treating genitourinary cancers.

Staffed by medical, surgical, and radiation oncologists, our multidisciplinary center offers the latest treatments fueled by ongoing research discovery.

Our genitourinary cancer experts work together to create an individualized treatment plan that offers you the most effective, comprehensive care available.

Administrative Leadership

Toni Choueiri, MD – Division Chief and Director, Lank Center for Genitourinary Oncology; Medical Director, International Strategic Initiatives at Dana-Farber

Mary-Ellen Taplin, MD – Chair, Executive Committee for Clinical Research

Joaquim Bellmunt, MD, PhD – Director, Bladder Cancer Center

Mark Pomerantz, MD – Clinical Director, Genitourinary Oncology; Director, Genitourinary Education

Kerry Kilbridge, MD, MSc – Director of Pathways, Genitourinary Oncology

Atish Choudhury, MD, PhD – Chair, Gelb Center for Translational Research

Bradley McGregor, MD – Clinical Research Director, Genitourinary Oncology

Xiao Wei, MD, MAS – Clinical Research Deputy Director, Genitourinary Oncology; Liaison to Immune Effector Cell (IEC) Therapy Program

Elizabeth Henske, MD – Director, Center for LAM Research and Clinical Care, Brigham and Women’s Hospital

Himisha Beltran, MD – Prostate SPORE Co-PI, Dana-Farber/Harvard Cancer Center; Director of Translational Research, Department of Medical Oncology

Eliezer Van Allen, MD – Chief, Division of Population Sciences, Dana-Farber

Matthew Vander Heiden, MD, PhD – Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Daniel Roberts, MD – Associate Medical Director for Quality, DFCI Network

Alicia Morgans, MD, MPH – Medical Director, Survivorship Program

Geraldine Sanon – Administrative Director, Genitourinary Oncology